Carolyn Ibberson

Carolyn Ibberson serves as an Assistant Professor of Microbiology at the University of Oklahoma, where she leads the Ibberson Lab focused on bacterial physiology in chronic human infections. Her research program addresses fundamental questions about how pathogens like Staphylococcus aureus establish and persist in chronic infections, with particular emphasis on polymicrobial interactions.

• B.S. in Biology from University of Wisconsin-Madison (2010)
• Ph.D. in Microbiology from University of Iowa (2015)
• Postdoctoral training at University of Texas at Austin (2015-2017) and Georgia Institute of Technology (2017-2021)

Dr. Ibberson's research focuses on understanding bacterial physiology during human infection, particularly examining how co-infecting microbes influence S. aureus behavior and disease severity. Her work bridges classic microbiology with advanced genomic and computational approaches to address why chronic polymicrobial infections are notoriously difficult to treat, representing a significant healthcare burden costing over $20 billion annually in the United States. Her laboratory employs next-generation sequencing, microscopy, computational pipelines, and deep learning to investigate the molecular mechanisms of bacterial persistence and microbe-microbe interactions in chronic infection settings.

Analysis of Dr. Ibberson's publications reveals a consistent focus on bacterial pathogenesis, particularly Staphylococcus aureus and Pseudomonas aeruginosa in human infections. Her work spans transcriptomics, biofilm formation, virulence factor regulation, and polymicrobial interactions, demonstrating an interdisciplinary approach that combines molecular microbiology with ecological and evolutionary perspectives. Her research trajectory shows increasing sophistication in methodologies, incorporating advanced genomic techniques and computational analysis to address complex questions in infection biology.

Dr. Ibberson maintains an active research program through the Ibberson Lab at the University of Oklahoma, where she mentors students and collaborators in cutting-edge microbiological research. While specific grant information isn't detailed in the available materials, her publication record suggests successful funding for research on bacterial physiology in chronic infections, polymicrobial communities, and pathogen adaptation mechanisms. Her work has significant implications for developing new therapeutic approaches for difficult-to-treat chronic infections.

The Ibberson Lab represents a dynamic research environment focused on understanding the fundamental biology of bacterial pathogens in clinically relevant contexts. The lab's work on spatial structure in microbial communities, host-pathogen interactions, and gene regulation during infection provides critical insights that could lead to novel antimicrobial strategies targeting the complex ecology of chronic infections.